Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2005
11/02/2005CN1691957A 蛋白酶抑制剂 Protease inhibitors
11/02/2005CN1691949A Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases
11/02/2005CN1691948A Adsorbent for oral administration
11/02/2005CN1691945A Use of rapamycin for inhibiting of cell death
11/02/2005CN1690057A Selenophen derivatives and their use for prevention and/or treatment of diseases relative to protein aging
11/02/2005CN1690041A Novel derivatives of 3, 3-diphenylpropylamines
11/02/2005CN1689576A Magnetic slow release 5-aminosalicylic acid with intercalate structure and its preparation method
11/02/2005CN1225542C Health care medicinal liquor
11/02/2005CN1225465C Novel compounds
11/02/2005CN1225464C Extraction technology of Hanbaicalein, medicinal composition and preparation technology of medicine
11/02/2005CN1225278C Nutrient healthy powder for delaying senescence
11/02/2005CN1225273C Nutritious health care food and preparation process thereof
11/02/2005CN1225268C 'Sanhuang' dripping pills and preparing method thereof
11/02/2005CN1225263C Chinese herbal medicine for birds and beasts use and its preparing method
11/02/2005CN1225257C External applied medicine for treating hepatitis
11/02/2005CN1225255C Health preserving tea
11/02/2005CN1225253C Health protection wine for improvement of inferior health
11/02/2005CN1225245C Use of Pidotimod in preparation of hepatitis B treating medicine
11/01/2005US6960674 A lipoxin compound for treating polymorphoneutrophil (PMN) inflammation
11/01/2005US6960609 Analgesics; central nervous system disorders; gastrointestinal disorder; therapy for drug abruse ; antiinflammatory agents
11/01/2005US6960602 Piperidine derivatives as modulators of chemokine receptors
11/01/2005US6960597 Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960585 For therapy of inflammatory and immune diseases
11/01/2005US6960581 1-amino-2-hydroxy-butane or 2-hydroxy-butanamide derivatives
11/01/2005US6960578 Glutamate receptor antagonists
11/01/2005US6960444 Transcriptional mediators of blood vessel development and endothelial differentiation
11/01/2005US6960343 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation
11/01/2005US6960341 Bifidobacteria and preparations containing them
11/01/2005CA2383351C Xanthine derivatives as selective antagonists of a2b adenosine receptors
10/2005
10/27/2005WO2005100987A1 Novel ligand of g protein coupled receptor protein and use thereof
10/27/2005WO2005100562A1 OSTEOPONTIN siRNA
10/27/2005WO2005100547A1 Dendritic cell obtained by antigen pulsing
10/27/2005WO2005100325A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
10/27/2005WO2005100324A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors
10/27/2005WO2005099760A1 Solid pharmaceutical preparation
10/27/2005WO2005099759A1 Medicine for prevention and/or treatment of arteriosclerosis
10/27/2005WO2005099753A1 Anti-gluten egg yolk antibodies for the treatment of celiac disease
10/27/2005WO2005099726A1 ANTI-ULCEROGENIC ACTIVITIES OF SESQUITERPENS AND POLYACETYLENES OF A DICHLOROMETHANIC EXTRACT OF Bidens alba L.
10/27/2005WO2005099725A1 Preventive and/or remedy for inflammatory bowel diseases
10/27/2005WO2005099698A1 STABILIZED 4-AMINO-5-CHLORO-N-[(1R,3r,5S)-8-METHYL-8- AZABICYCLO[3.2.1]OCT-3-YL]-2-[1-METHYLBUT-2-YNYLOXY]-BENZAMIDE CONTAINING COMPOSITION
10/27/2005WO2005099686A1 Edible composition having effects of promoting the production and release of calcitonin gene-related peptide
10/27/2005WO2005099681A1 Tablet containing branched chain amino acid and process for producing the same
10/27/2005WO2005007699A8 Human antibody molecules for il-13
10/27/2005WO2003023008A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/27/2005US20050240023 Cathepsin cysteine protease inhibitors
10/27/2005US20050239905 Smooth muscle peristole inhibitor
10/27/2005US20050239891 Use of citrulline within the framework of intestinal insufficiency
10/27/2005US20050239883 Composition for lowering internal lipid content
10/27/2005US20050239870 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; aminoalkylamide, piperidine-, indole-, or pyrrole-amide derivatives; anticarcinogenic agents
10/27/2005US20050239861 Administering isolated and optically active 4-amino-5-chloro-2-methoxy-N-[(2S,4S)- 2-hydroxymethyl-4-pyrrolidinyl]benzamide, which has high binding affinity for a serotonin receptor 4 (5HT4) and does not cause arteritis or thrombus formation for improving movement of digestive tract
10/27/2005US20050239852 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors
10/27/2005US20050239851 Substituted benzoxazoles as estrogenic agents
10/27/2005US20050239846 Use of vanilloid receptor antagonists for the treatment of pain
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239824 Triple monoamine reuptake inhibitors for the treatment of chronic pain
10/27/2005US20050239815 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor
10/27/2005US20050239789 2-(9-bromo-3,4,10,10a-tetrahydro-1H-pyrazino[1,2-a]indol-2-yl)-cyclobutanone; treating disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes insipidus, obesity and sleep apnea
10/27/2005US20050239786 Triazole derivatives as tachykinin receptor antagonists
10/27/2005US20050239780 Tetrahydropyran derivative
10/27/2005US20050239776 Tachykinin receptor antagonists
10/27/2005US20050239774 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
10/27/2005US20050239773 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction
10/27/2005US20050239732 Immunostimulatory nucleic acid molecules
10/27/2005US20050239712 Pharmaceutically active compound
10/27/2005US20050239201 Methods of inducing differentiation of stem cells into a specific cell lineage
10/27/2005US20050239170 Alpha-MSH related compounds and methods of use
10/27/2005US20050239169 Nucleotide sequences coding seladin-1polypeptide for use in treatment and prevention of alzheimer's disease
10/27/2005US20050239141 Modified antibody variable domains
10/27/2005US20050238590 Incorporation of exogenous lactic bacteria into the oral microflora
10/27/2005CA2562473A1 Preventive and/or therapeutic agent for inflammatory bowel diseases
10/27/2005CA2562391A1 Solid pharmaceutical preparation
10/26/2005EP1589115A2 Polymorphisms of the human organic anion transporting polypeptide-C (OATP-C)
10/26/2005EP1589033A1 Antibody and use thereof
10/26/2005EP1589013A2 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/26/2005EP1589007A2 5-membered heterocycle derivatives, production thereof and their use as medicaments
10/26/2005EP1589006A1 Oxa- and thiazole derivatives useful as antidiabetics and antidiobesity agents
10/26/2005EP1588707A1 Stable solid medicinal composition for oral administration
10/26/2005EP1588706A2 Use of AT1 receptor antagonists or AT2 receptor modulator for the treatment of conditions or diseases associated with the increase of AT1 or AT2 receptors.
10/26/2005EP1587805A1 Paharmaceutical process and compounds prepared thereby
10/26/2005EP1587531A2 Hcv combination therapy
10/26/2005EP1587530A2 The use of yop proteins or rho gtpase inhibitors as caspase-1 inhibitors
10/26/2005EP1587477A2 Odorless formulation for treating mucosal discontinuities
10/26/2005EP1587364A2 Method for identifying novel treatments of inflammatory disease in the gut
10/26/2005EP1440071B1 Imidazopyridine compounds as 5-ht 4? receptor modulators
10/26/2005EP1397354B1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
10/26/2005EP1397133B1 Rapid onset formulation
10/26/2005EP1289965B1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
10/26/2005EP1185277B1 Use of FXR synthetic ligands for the treatment of diseseas linked to cholesterol imbalance and colon cancer
10/26/2005EP1159455B1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
10/26/2005EP1131312B1 Novel pyrimidine derivatives and processes for the preparation thereof
10/26/2005EP1087778B1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
10/26/2005EP1073415B1 Pharmaceutical compositions capable of being gelled
10/26/2005EP0910428B1 Photopheresis treatment of chronic hcv infections
10/26/2005CN1688707A Tiacumicin production
10/26/2005CN1688606A Novel immunogenic lipopeptides comprising T-helper and B-cell epitopes
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688578A Phosphodiesterase 4 inhibitors
10/26/2005CN1688577A Triazaspiro [5.5] undecane derivatives and drugs comprising the same as the active ingredient
10/26/2005CN1688549A Compound having TGF-beta inhibitory activity and medicinal composition containing the same
1 ... 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 ... 1258